B-UNITED Trial NCT06537414: Phase 2, Active, not recruiting

Tracking

Comparisons

Automation

Nightly sweep

Loading…

B-UNITED Trial NCT06537414: Phase 2, Active, not recruiting | ComplyRx

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)